Deborah J. Kissire - Apr 30, 2021 Form 4 Insider Report for Celanese Corp (CE)

Role
Director
Signature
/s/ Michael R. Sullivan, Attorney-in-Fact for Deborah J. Kissire
Stock symbol
CE
Transactions as of
Apr 30, 2021
Transactions value $
$513
Form type
4
Date filed
8/11/2021, 04:38 PM
Next filing
May 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CE Common Stock Disposed to Issuer -754 -41.22% 1.08K Apr 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CE Phantom Stock Award $0 +754 $0.00 754 Apr 30, 2021 Common Stock 754 Direct F2, F3
transaction CE Phantom Stock Award $513 +3.28 +0.43% $156.50 757 Aug 9, 2021 Common Stock 3.28 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Upon vesting of 754 Restricted Stock Units granted to the reporting person on October 14, 2020, the reporting person deferred the receipt of 754 shares of Common Stock and received instead 754 shares of phantom stock pursuant to the Company's 2008 Deferred Compensation Plan (the "Plan"). As a result, the reporting person is reporting the disposition of 754 shares of Common Stock in exchange for an equal number of shares of phantom stock.
F2 Each share of phantom stock represents the right to receive one share of Common Stock.
F3 As provided in the Plan, the reported phantom stock becomes payable in shares of Common Stock upon termination of the reporting person's service as a director of the Company subject to certain restrictions and limitations.
F4 The reported phantom stock represents dividend equivalents on compensation deferred under the Plan. The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.